Chikungunya Outbreak China (September 2025): Traveler's Guide & Prevention
China mosquito Virus Updates - Understanding the Virus and Prevention
Updates as of Early September 2025
Global Situation and Key Numbers
The Chikungunya outbreak of 2025 continues to be a major global health challenge. According to recent reports from the European Centre for Disease Prevention and Control (ECDC), as of early September 2025, over 240,000 cases and 90 related deaths have been reported across 16 countries. This is an increase from previous months, showing the virus is still actively spreading.
One of the most concerning developments is the virus's spread into regions that were not previously considered at high risk. This is being linked to several factors, including:
-
Climate Change: Warmer temperatures are allowing the Aedes mosquitoes that carry the virus to expand their territory.
-
Urbanization: Dense city populations provide ideal environments for mosquitoes to breed and spread the virus.
-
International Travel: Infected travelers are carrying the virus to new, non-endemic areas.
Global Situation and Key Numbers
The Chikungunya outbreak of 2025 continues to be a major global health challenge. According to recent reports from the European Centre for Disease Prevention and Control (ECDC), as of early September 2025, over 240,000 cases and 90 related deaths have been reported across 16 countries. This is an increase from previous months, showing the virus is still actively spreading.
The most significant new development in the outbreak is the situation in southern China. The country is experiencing its largest recorded outbreak of the virus to date, centered in Guangdong Province.
-
Case Numbers: As of early September, a total of over 10,000 cases have been reported in the province since the outbreak began in June. The primary hotspot is Foshan City, which has reported over 7,000 cases alone. Local authorities noted a new peak in cases in July before a decline in new infections was reported in late August and early September.
-
Public Health Response: In response to the rapid spread, Chinese authorities have implemented strict, and in some cases, aggressive control measures. These have included tactics similar to those used during the COVID-19 pandemic.
-
Vector Control: Mass spraying of insecticides, deploying drones to locate and spray mosquito breeding grounds, and ordering residents to remove stagnant water from their homes and yards. In some areas, fines of up to 10,000 yuan were introduced for non-compliance.
-
Case Management: Hospitals in Foshan have reportedly been isolating patients in special "quarantine wards" with mosquito nets and screens to prevent further transmission.
-
-
Travel Alerts: In light of the outbreak, the U.S. Centers for Disease Control and Prevention (CDC) has issued a Level 2 Travel Health Advisory for Guangdong Province, advising travelers to "Practice Enhanced Precautions." Hong Kong has also confirmed imported cases linked to travel from the mainland.
Global Spread
-
European Outbreaks: Europe has seen a concerning rise in locally-acquired (autochthonous) cases. As of early September, France and Italy have reported hundreds of cases, with multiple active clusters.
-
France: Reported over 300 locally-acquired cases, with the largest cluster located in Vitrolles.
-
Italy: Has seen over 100 locally-acquired cases, with the largest cluster in the Carpi, San Prospero, and Soliera areas.
-
-
Americas and Asia: The Americas continue to report the highest number of cases globally, with Brazil, Bolivia, Argentina, and Peru being heavily affected. In Asia, significant outbreaks have been confirmed in China, India, and Sri Lanka.
-
Travel Advisories: The U.S. Centers for Disease Control and Prevention (CDC) has issued Level 2 travel health advisories for several affected regions, including parts of the Indian Ocean and China, urging travelers to practice enhanced precautions.
European Centre for Disease Prevention and Control (ECDC). (2025). Seasonal surveillance for chikungunya virus disease in the EU/EEA for 2025. Retrieved from https://www.ecdc.europa.eu/en/chikungunya-virus-disease/surveillance-and-updates/seasonal-surveillance
Government Information Centre (Hong Kong). (2025). Update on chikungunya fever. Retrieved from https://www.info.gov.hk/gia/general/202509/03/P2025090300604.htm
📌CHICKV: Quick Facts and Summary
​
-
Chikungunya virus (CHIKV) is a mosquito-borne illness currently experiencing a significant outbreak in China's Guangdong province (August 2025).
-
It's primarily spread by Aedes mosquitoes (daytime biters).
-
Main symptoms include sudden high fever and severe joint pain, which can be debilitating.
-
The fatality rate is low (around 1 in 1,000 cases), but severe complications can occur in infants and the elderly.
-
Prevention focuses on mosquito bite avoidance and eliminating breeding grounds.
-
Unlike West Nile virus, Chikungunya is known for its severe, often long-lasting, joint pain.

Understanding the new Virus in China, Prevention, and Staying Safe
For international travelers, staying informed about global health concerns is crucial. As of August 2025, a significant outbreak of the Chikungunya virus (CHIKV) is being reported in southern China, primarily in Guangdong province. While rarely fatal, Chikungunya can cause severe and long-lasting symptoms, making awareness and prevention essential for anyone planning to visit or currently in the affected regions.
New Virus in China: Essential FAQ
​
1. Is there a vaccine for Chikungunya?
Currently, two vaccines for Chikungunya have been approved in some countries but are not yet widely used or available globally. Prevention through mosquito bite avoidance remains the primary strategy.
​
2. How serious is the Chikungunya outbreak in China?
As of August 2025, it's considered the largest Chikungunya outbreak ever documented in mainland China, with over 7,000 cases reported in Guangdong province. Authorities are implementing strict containment measures.
​
3. Can Chikungunya spread from person to person?
No, Chikungunya is a mosquito-borne virus and does not spread directly from person to person. It requires an infected mosquito to transmit the virus.
​
4. What are the main symptoms of Chikungunya?
The most common symptoms are a sudden high fever and severe joint pain. Other symptoms can include muscle aches, headache, rash, fatigue, and joint swelling.
​
5. How long do Chikungunya symptoms last?
Acute symptoms usually last about a week. However, the severe joint pain can persist for weeks, months, or even years, particularly in older adults.
​
6. What should I do if I get bitten by a mosquito in a Chikungunya-affected area?
Monitor yourself for symptoms. If you develop fever and joint pain within 2-12 days of a bite, seek medical attention and inform your doctor about your travel history.
​
7. Is it safe to travel to Guangdong province in China right now?
The U.S. CDC has issued a Level 2 travel advisory, recommending "increased caution." While the virus is rarely fatal, its symptoms can be debilitating. Travelers should take enhanced mosquito bite prevention measures.
​
8. How does climate change affect Chikungunya outbreaks?
Rising global temperatures and changes in rainfall patterns can expand the geographic range of Aedes mosquitoes and create more breeding grounds, potentially leading to more frequent and intense outbreaks.
​
9. What's the difference in long-term effects between Chikungunya and West Nile virus?
Chikungunya is primarily known for its severe, often chronic, joint pain. West Nile virus, while usually mild, can lead to more severe neurological effects like meningitis or encephalitis in a small percentage of cases.
​
10. Can I get Chikungunya if I'm pregnant?
Pregnant travelers, especially those near delivery, should reconsider visits to outbreak zones as transmission to newborns is possible, potentially leading to severe disease in the infant.



1. What is Chikungunya Virus (CHICKV)?
Chikungunya is a viral disease spread to humans through the bite of infected mosquitoes, mainly the Aedes aegypti (yellow fever mosquito) and Aedes albopictus (Asian tiger mosquito). These mosquitoes are often active during the daytime. The name "Chikungunya" comes from the Makonde language of East Africa, meaning "to become contorted," referring to the stooped appearance of those suffering from the severe joint pain it causes.
2. Current Outbreak in China: August 2025
As of August 2025, China is battling one of its largest Chikungunya outbreaks on record.
-
Where it was spotted: The epicenter of the outbreak is the manufacturing hub of Foshan in Guangdong Province. Cases have also been reported in nearby cities like Guangzhou, Shenzhen, Dongguan, and Zhongshan. Hong Kong has also reported an imported case linked to travel to Foshan.
-
Scale of Outbreak: Over 7,000 cases have been reported in Guangdong province since July 2025. While authorities indicate a slow decline in new cases, the outbreak is significant due to Chikungunya never being established in mainland China before, meaning much of the population lacks prior immunity.
-
Containment Measures: Chinese authorities have implemented strict measures, including mandatory hospitalization for confirmed patients (often in mosquito-proof wards), aggressive mosquito control (insecticide spraying, releasing larva-eating fish, using drones to find breeding sites, and even deploying predatory "elephant mosquitoes"), and fines for residents who fail to eliminate stagnant water. The U.S. CDC has issued a Level 2 travel advisory, urging increased caution for travelers to Guangdong.
3. Transmission, Symptoms, and Fatality Rate
-
Transmission: Chikungunya is transmitted when an infected Aedes mosquito bites a person, and then that same mosquito bites another person. It does not spread directly from person to person.
-
Symptoms: Symptoms typically appear 3 to 7 days (incubation period can range from 2-12 days) after a mosquito bite.
-
Sudden high fever (above 39°C or 102°F).
-
Severe joint pain, often debilitating, affecting multiple joints symmetrically (e.g., both wrists, both ankles). This pain can persist for weeks, months, or even years, especially in older adults or those with pre-existing joint conditions.
-
Other symptoms may include muscle aches, headache, fatigue, rash (reddening with small bumps on palms, soles, torso, face), and joint swelling.
-
-
Fatality Rate: The overall fatality rate for Chikungunya is low, around 1 in 1,000 cases. However, severe complications (e.g., neurological issues, organ dysfunction) and fatalities are more likely in vulnerable populations, including young infants, the elderly (over 65), and individuals with underlying chronic medical problems.
4. Chikungunya vs. West Nile Virus: A Comparison:
Both Chikungunya and West Nile virus (WNV) are mosquito-borne illnesses,
but they differ in key aspects:
​
​
​
​
​
​
​
5. Prevention: How to Stay Safe
Since there is no widely available vaccine or specific antiviral treatment for Chikungunya, prevention through mosquito bite avoidance is the best protection.
-
Use Insect Repellent: Apply insect repellents containing DEET, Picaridin, or Oil of Lemon Eucalyptus on exposed skin. Always follow product instructions.
-
Wear Protective Clothing: Wear long-sleeved shirts, long pants, and socks, especially during the daytime when Aedes mosquitoes are most active.
-
Sleep Under Mosquito Nets: If staying in accommodations without air conditioning or good window screens, sleep under a permethrin-treated mosquito net.
-
Eliminate Breeding Grounds: Mosquitoes lay eggs in standing water. Regularly empty, clean, or cover containers that hold water (flowerpots, buckets, old tires). Change water in birdbaths and pet bowls frequently. Keep drains unclogged and gutters clean.
-
Stay in Screened/Air-Conditioned Places: Choose accommodations that are well-screened or have air conditioning to keep mosquitoes out.
-
Be Aware of Peak Times: While Aedes mosquitoes bite during the day, they are often most active during early morning and late afternoon/early evening.
6. Seeking Medical Attention Abroad
If you develop symptoms of Chikungunya while traveling in China or after returning home, seek medical attention promptly. Inform your healthcare provider about your recent travel history. While there's no specific cure, supportive care can help manage symptoms and prevent complications.
Where is China's Guangdong province?
Guangdong province is the primary location of the significant Chikungunya virus outbreak in China as of August 2025. The outbreak's epicenter is the city of Foshan, with additional cases reported in nearby cities within Guangdong, such as Guangzhou, Shenzhen, Dongguan, and Zhongshan. The U.S. CDC has issued a Level 2 travel advisory for travelers to Guangdong, recommending increased caution due to the outbreak. Chinese authorities are implementing strict containment measures in the province to curb the spread of the virus.

Major Airports in Guangdong Province
-
Guangzhou Baiyun International Airport (CAN): Located in Guangzhou, this is one of China's busiest airports by passenger traffic and a major hub for China Southern Airlines. It serves as a primary gateway to southern China.
-
Shenzhen Bao'an International Airport (SZX): Located in Shenzhen, this airport is another key international hub in Guangdong, serving the Pearl River Delta region.
International Flight Connectivity
Both Guangzhou Baiyun International Airport (CAN) and Shenzhen Bao'an International Airport (SZX) have extensive international flight networks, connecting Guangdong province to numerous cities across the globe.
Guangzhou Baiyun International Airport (CAN) offers direct international flights to major cities in:
-
Europe: Such as London, Paris, Frankfurt, Amsterdam, Rome, Milan, Istanbul, and Moscow.
-
North America: Including Los Angeles, New York City, and San Francisco.
-
Asia: Extensive connections to Tokyo, Seoul, Singapore, Bangkok, Kuala Lumpur, Hong Kong, Manila, New Delhi, Mumbai, and many other regional destinations.
-
Middle East & Africa: Flights to Dubai, Doha, Riyadh, Cairo, Addis Ababa, and Johannesburg.
-
Oceania: Connections to Sydney and Auckland.
Shenzhen Bao'an International Airport (SZX) also has a growing international presence with direct flights to:
-
Europe: Including London, Paris, Frankfurt, Brussels, Rome, Milan, and Madrid.
-
Asia: Strong connectivity to Tokyo, Seoul, Singapore, Bangkok, Kuala Lumpur, Manila, and other Southeast Asian cities.
-
Middle East: Flights to Dubai and Tel Aviv.
-
Oceania: Connections to Sydney and Auckland.
These airports serve as crucial entry and exit points for international travelers to and from Guangdong province, facilitating both business and tourism
Can CHICKV be compared to Malaria?
Yes, Chikungunya virus (CHIKV) and Malaria can be compared, as they are both significant mosquito-borne diseases that pose risks to international travelers. However, it's crucial to understand their distinct differences in terms of the pathogen, vector, symptoms, and treatment.
CHICKV and Malaria Comparison
Most Active 2 hours after sunrise and 4-5 hours before sunset
Most Active usually between 5 to 9 PM
Bite in daylight and well-lit areas at night
Key Symptoms | Sudden high fever, severe, often debilitating joint pain (can be chronic), rash, muscle aches
Long-term Effects | Persistent joint pain (months to years) is common
Fatality Rate | Low (around 1 in 1,000 cases); higher in infants, elderly, or those with underlying conditions.
Geographic Risk | Widespread in tropical/subtropical regions of Africa, Asia, Americas, Europe. Recent outbreaks in China.
Start biting in late evening, peak at midnight to early morning
Cyclical fever, chills, sweating, headache, muscle pain, fatigue. Can lead to severe anemia, organ failure, or cerebral malaria.
Recurrent episodes (relapses), severe anemia, organ damage if untreated
Higher, especially with P. falciparum if untreated. WHO reported 597,000 deaths in 2023
Primarily tropical and subtropical regions, especially Sub-Saharan Africa, parts of Asia, and Latin America.
CHICK V and Malaria Similarities:
​Despite their differences, Chikungunya and Malaria share critical similarities for travelers:
-
Mosquito-borne: Both are transmitted exclusively through mosquito bites.
-
Flu-like Onset: Initial symptoms can often mimic the flu, making early diagnosis challenging without testing.
-
Prevention Focus: For both, avoiding mosquito bites is the primary and most effective prevention strategy.
-
Global Health Threat: Both diseases contribute significantly to global disease burden and are major concerns for public health organizations and travelers.
References and Source of Information
-
World Health Organization (WHO): "GLOBAL CHIKUNGUNYA EPIDEMIOLOGY UPDATE" (June 11, 2025), "Chikungunya fact sheet" (April 14, 2025), "Outbreak of Chikungunya Virus Poses Global Risk, Warns WHO" (July 23, 2025).
-
U.S. Centers for Disease Control and Prevention (CDC): Travel advisories and information on Chikungunya.
-
Times of India: "Chikungunya Virus outbreak in China: Which countries are at risk and how to manage the symptoms (prevention tips inside)" (August 6, 2025), "Rare virus: Chikungunya infects 7,000+ in Guangdong outbreak; covid like rules return as public worries" (August 5, 2025).
-
Time.com: "What to Know About Chikungunya Amid Southern China Outbreak of Mosquito-Borne Virus" (August 5, 2025).
-
Wikipedia: "Chikungunya" and "West Nile virus" articles.
-
Academic Journals (e.g., AAFP, MDPI): "Emerging Vector-Borne Diseases" (October 1, 2016), "Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication" (September 11, 2024).
-
World Health Organization (WHO): "GLOBAL CHIKUNGUNYA EPIDEMIOLOGY UPDATE" (June 11, 2025), "Chikungunya fact sheet" (April 14, 2025), "Malaria fact sheet" (December 11, 2024).
-
U.S. Centers for Disease Control and Prevention (CDC): Travel advisories and information on both diseases.
-
Mayo Clinic: "Malaria - Symptoms & causes" and "Jellyfish stings - Symptoms and causes" articles.
-
Academic and Medical Journals (e.g., AAFP, MDPI, PLOS): "Emerging Vector-Borne Diseases" (October 1, 2016), "Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication" (September 11, 2024), "Clinical Features of Severe Malaria Associated with Death: A 13-Year Observational Study in The Gambia" (September 28, 2012).
-
Apollo Hospitals: "Dengue, Malaria, Chikungunya: Differences & Similarities" (February 18, 2025).
-
Redcliffe Labs: "How to Differentiate Between Dengue, Malaria, and Chikungunya?" (May 10, 2025).

Disclaimer: The information in this article is for general informational purposes only and does not constitute medical advice. The Chikungunya outbreak situation is evolving rapidly, and the data provided is accurate as of August 10, 2025. Always consult with local health authorities or a healthcare professional for the most current information and personalized medical guidance. TravelHealth.pro is not liable for any actions taken based on the information provided herein.
